Fresenius SE & Co. KGaA (FRE.DE)
EUR 34.19
(0.41%)
EUR 34.19
(0.41%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 3.91 Billion EUR | -47.12% |
| 2022 | 7.4 Billion EUR | 20.33% |
| 2021 | 6.15 Billion EUR | 3.2% |
| 2020 | 5.96 Billion EUR | 3.76% |
| 2019 | 5.74 Billion EUR | 6.57% |
| 2018 | 5.39 Billion EUR | -8.41% |
| 2017 | 5.88 Billion EUR | 22.62% |
| 2016 | 4.8 Billion EUR | 3.05% |
| 2015 | 4.65 Billion EUR | 24.97% |
| 2014 | 3.72 Billion EUR | 9.91% |
| 2013 | 3.39 Billion EUR | 2.63% |
| 2012 | 3.3 Billion EUR | 7.44% |
| 2011 | 3.07 Billion EUR | 5.78% |
| 2010 | 2.9 Billion EUR | 12.63% |
| 2009 | 2.58 Billion EUR | 5.34% |
| 2008 | 2.45 Billion EUR | 476.5% |
| 2007 | -651 Million EUR | -8.5% |
| 2006 | -600 Million EUR | -8.89% |
| 2005 | -551 Million EUR | -56.09% |
| 2004 | -353 Million EUR | -123.24% |
| 2003 | 1.51 Billion EUR | -6.58% |
| 2002 | 1.62 Billion EUR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 958 Million EUR | 13.11% |
| 2024 Q1 | 847 Million EUR | -30.12% |
| 2023 Q4 | 1.21 Billion EUR | 30.89% |
| 2023 FY | 3.91 Billion EUR | -47.12% |
| 2023 Q1 | 1.72 Billion EUR | -17.79% |
| 2023 Q2 | 1.79 Billion EUR | 3.83% |
| 2023 Q3 | 926 Million EUR | -48.27% |
| 2022 Q3 | 1.81 Billion EUR | -0.82% |
| 2022 Q4 | 2.09 Billion EUR | 15.35% |
| 2022 FY | 7.4 Billion EUR | 20.33% |
| 2022 Q1 | 1.65 Billion EUR | 4.22% |
| 2022 Q2 | 1.83 Billion EUR | 10.69% |
| 2021 Q4 | 1.58 Billion EUR | 4.88% |
| 2021 Q2 | 1.59 Billion EUR | 9.99% |
| 2021 Q1 | 1.45 Billion EUR | -7.98% |
| 2021 Q3 | 1.51 Billion EUR | -5.13% |
| 2021 FY | 6.15 Billion EUR | 3.2% |
| 2020 Q4 | 1.57 Billion EUR | 13.2% |
| 2020 Q1 | 1.58 Billion EUR | 7.99% |
| 2020 Q2 | 1.43 Billion EUR | -9.42% |
| 2020 Q3 | 1.39 Billion EUR | -2.72% |
| 2020 FY | 5.96 Billion EUR | 3.76% |
| 2019 FY | 5.74 Billion EUR | 6.57% |
| 2019 Q1 | 1.38 Billion EUR | 1.54% |
| 2019 Q4 | 1.46 Billion EUR | 1.67% |
| 2019 Q3 | 1.44 Billion EUR | -0.69% |
| 2019 Q2 | 1.45 Billion EUR | 4.46% |
| 2018 Q3 | 1.36 Billion EUR | -0.66% |
| 2018 Q4 | 1.36 Billion EUR | 0.37% |
| 2018 FY | 5.39 Billion EUR | -8.41% |
| 2018 Q1 | 1.3 Billion EUR | -16.48% |
| 2018 Q2 | 1.37 Billion EUR | 5.38% |
| 2017 Q1 | 1.47 Billion EUR | 18.92% |
| 2017 Q4 | 1.55 Billion EUR | 13.22% |
| 2017 Q3 | 1.37 Billion EUR | -6.58% |
| 2017 FY | 5.88 Billion EUR | 22.62% |
| 2017 Q2 | 1.47 Billion EUR | -0.2% |
| 2016 Q4 | 1.24 Billion EUR | 1.31% |
| 2016 Q2 | 1.15 Billion EUR | -2.62% |
| 2016 Q1 | 1.18 Billion EUR | -4.6% |
| 2016 FY | 4.8 Billion EUR | 3.05% |
| 2016 Q3 | 1.22 Billion EUR | 6.52% |
| 2015 Q1 | 1.05 Billion EUR | -0.09% |
| 2015 FY | 4.65 Billion EUR | 24.97% |
| 2015 Q4 | 1.23 Billion EUR | 5.09% |
| 2015 Q3 | 1.17 Billion EUR | -0.76% |
| 2015 Q2 | 1.18 Billion EUR | 12.82% |
| 2014 FY | 3.72 Billion EUR | 9.91% |
| 2014 Q2 | 861 Million EUR | 0.82% |
| 2014 Q3 | 959 Million EUR | 11.38% |
| 2014 Q4 | 1.05 Billion EUR | 9.91% |
| 2014 Q1 | 854 Million EUR | -0.12% |
| 2013 Q2 | 860 Million EUR | 2.5% |
| 2013 Q3 | 838 Million EUR | -2.56% |
| 2013 Q4 | 855 Million EUR | 2.03% |
| 2013 FY | 3.39 Billion EUR | 2.63% |
| 2013 Q1 | 839 Million EUR | -8.71% |
| 2012 Q4 | 919 Million EUR | 15.6% |
| 2012 FY | 3.3 Billion EUR | 7.44% |
| 2012 Q2 | 813 Million EUR | 4.5% |
| 2012 Q1 | 778 Million EUR | -4.54% |
| 2012 Q3 | 795 Million EUR | -2.21% |
| 2011 Q3 | 757 Million EUR | 0.66% |
| 2011 Q4 | 815 Million EUR | 7.66% |
| 2011 FY | 3.07 Billion EUR | 5.78% |
| 2011 Q2 | 752 Million EUR | 0.0% |
| 2011 Q1 | 752 Million EUR | 3.16% |
| 2010 FY | 2.9 Billion EUR | 12.63% |
| 2010 Q4 | 729 Million EUR | -4.83% |
| 2010 Q2 | 743 Million EUR | 10.4% |
| 2010 Q1 | 673 Million EUR | 1.66% |
| 2010 Q3 | 766 Million EUR | 3.1% |
| 2009 Q3 | 645 Million EUR | -2.27% |
| 2009 Q2 | 660 Million EUR | 7.32% |
| 2009 Q1 | 615 Million EUR | 0.0% |
| 2009 FY | 2.58 Billion EUR | 5.34% |
| 2009 Q4 | 662 Million EUR | 2.64% |
| 2008 FY | 2.45 Billion EUR | 476.5% |
| 2007 FY | -651 Million EUR | -8.5% |
| 2006 FY | -600 Million EUR | -8.89% |
| 2005 FY | -551 Million EUR | -56.09% |
| 2004 FY | -353 Million EUR | -123.24% |
| 2003 FY | 1.51 Billion EUR | -6.58% |
| 2002 FY | 1.62 Billion EUR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Fresenius Medical Care AG & Co. KGaA | 3.55 Billion EUR | -10.109% |
| LIMES Schlosskliniken AG | 11.2 Million EUR | -34837.629% |
| M1 Kliniken AG | 16.77 Million EUR | -23240.385% |
| Maternus-Kliniken Aktiengesellschaft | 17.48 Million EUR | -22294.463% |
| MEDICLIN Aktiengesellschaft | 70.03 Million EUR | -5490.102% |
| RHÖN-KLINIKUM Aktiengesellschaft | 162.47 Million EUR | -2309.587% |
| VITA 34 AG | 31.36 Million EUR | -12382.464% |